Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/21/2000US6150515 Nucleic acid of defined nucleotide sequence which encodes a tat-stimulatory factor protein; for drug screening of viricides for treatment of human immunodeficiency virus
11/21/2000US6150514 14 Kilobase deletion in the promoter region of BRCA1 in a breast cancer family
11/21/2000US6150511 Chimeric enzyme for promoting targeted integration of foreign DNA into a host genome
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150507 Method for producing a purified hemoglobin product
11/21/2000US6150506 Globin-like polypeptide having two dialpha domains; synthetic blood; antiischemic agents; antihypoxia agents; drug delivery; in vivo imaging; treatment of sickle cell anemia
11/21/2000US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free
11/21/2000US6150504 Process for the purification of serum albumin
11/21/2000US6150503 Phosphorylated fusion proteins
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150500 Activators of endothelial nitric oxide synthase
11/21/2000US6150393 N-(3-(4-bromo-1-methylpyrazol-3-yl)phenyl)(phenylmethylamino) -carboxamide modifier of activity of the serotonin 5-ht 2a; cns, gastrointestinal and cardiovascular disorders; antiinflammatory agents; side effect reduction
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150332 Alpha1-antitrypsin and peptide fragments and derivatives thereof are used to upregulate low density lipoprotein cholesterol receptor levels in the liver, resulting in a decrease in circulating ldl cholesterol levels
11/21/2000US6150329 Multimeric antithrombotic agents
11/21/2000US6150328 Purified bone morphogenic proteins-2 and 4 for use in the treatment of bone and cartilage defects and in wound healing and related tissue repair
11/21/2000US6150327 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/21/2000US6150176 Fluorescent protein sensors for measuring the pH of a biological sample
11/21/2000US6150172 Solvent extraction of isotonic or hypotonic aqueous preparation of biological material and increasing lyotropic activity of mixture to separate solvent from preparation to produce solvent containing abnormal prion protein; diagnosis
11/21/2000US6150169 Inserting a coding sequence into a target endogenous gene in a mouse embryonic stem cell genome by transforming with vector having specific dna construct and allowing homologous recombination
11/21/2000US6150168 Complex containing a binding molecule which non-covalently binds to the nucleic acid and covalently links to a surface ligand and a nuclear ligand; for gene therapy
11/21/2000US6150165 Polynucleotide which encodes a delta-endotoxin active against coleopteran pests; biological pest control; transgenic plants; treatment of plants and seeds
11/21/2000US6150161 Methods for the diagnosis of glaucoma
11/21/2000US6150156 Bacillus thuringiensis isolates active against sucking insects
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150149 Nucleotide and amino acid sequence; recombinant production; for use in breeding technology of basidiomycetes fungi and plants
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150138 Expression of a foamy virus envelope protein
11/21/2000US6150137 Immunosuppressant target proteins
11/21/2000US6150136 Nucleotide sequence encoding oligodendrocyte-specific protein
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150131 Screening for viricides that suppress interactions between cysteine and palmitic acid; mix cells infected with influenza virus, palmitic acid and modulator, monitor reduction in palmitic acid incorporation
11/21/2000US6150125 Flea protease proteins and uses thereof
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150110 HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use
11/21/2000US6150109 Lipophilic quenching of viral inactivating agents
11/21/2000US6150104 Nucleotide sequences coding a mutant polypeptide associated with ionic mobility; for the diagnosis of genetic disorders associated with heart arrythmias
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150090 Nuclear factors associated with transcriptional regulation
11/21/2000US6150088 Core structure of gp41 from the HIV envelope glycoprotein
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6150081 Nucleated with peptizer
11/21/2000US6149945 Irradiating culture of normal, fibroblast cells with gamma rays; incubating said cells; releasing dna synthesis inhibiting factor (sif) or mitosis inhibiting factor (mif) from cells; centrifuging; concentrating supernatant
11/21/2000US6149920 Vaccine for immunization, prophylaxis or treatment of a vertebrate at risk of or suffering from brucellosis, wherein said vaccine comprises an attenuated or avirulent strain of an otherwise pathogenic bacteria of the genus brucella
11/21/2000US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
11/21/2000US6149916 Methods of accelerating wound healing or of stimulating connective tissue cell growth using connective tissue growth factor
11/21/2000US6149911 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
11/21/2000US6149910 Peptides for the detection of HIV-1 group O
11/21/2000US6149906 Activation of t-lymphocytes and induction of antigen-specific immune responses; preventing, treating various diseases ( viral, bacterial, fungal), botulism toxin, poison ivy, poison sumac
11/21/2000US6149905 Administering a modifying tumor cells from a mammalian subject to express a b7 molecule; preventing or inhibiting metastatic spread of a tumor
11/21/2000US6149903 Suppressing the growth of an epithelial ovarian tumor in a mammal by injecting a genetic engineered vector to an intraperitoneal cavity of the mammal at the site of tumor
11/21/2000US6149902 Manipulation of non-terminally differentiated cells using the notch pathway
11/21/2000CA2166691C Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development
11/21/2000CA2038578C Delivery of agents
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/21/2000CA1341142C Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
11/16/2000WO2000068430A1 Rnase p polypeptides, polynucleotides, and methods using their mechanisms of action
11/16/2000WO2000068428A1 Methods for producing modified nucleic acid molecules
11/16/2000WO2000068427A1 yphC
11/16/2000WO2000068426A1 Ups
11/16/2000WO2000068425A1 ysxC
11/16/2000WO2000068420A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000WO2000068416A2 Method for localising proteases which split substrates that are specifically connected by a membrane
11/16/2000WO2000068406A2 Disease resistance factors
11/16/2000WO2000068405A2 Plant defensins
11/16/2000WO2000068404A1 Maize rad50 orthologue and uses thereof
11/16/2000WO2000068403A2 Tapetum-specific promoters
11/16/2000WO2000068401A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000WO2000068400A1 Method for producing a recombinant protein
11/16/2000WO2000068398A1 Purification method by affinity
11/16/2000WO2000068392A1 Plant-derived antigens against respiratory syncytial virus
11/16/2000WO2000068390A2 Plant recombination proteins
11/16/2000WO2000068389A2 Auxin transport proteins
11/16/2000WO2000068388A1 Seed specific promoters
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068378A1 Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
11/16/2000WO2000068377A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068373A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000WO2000068372A1 Combinatorial metabolic libraries
11/16/2000WO2000068370A2 ib00180US MAIS
11/16/2000WO2000068270A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000WO2000068269A1 Constitutive chimeric receptors, and methods of use thereof
11/16/2000WO2000068267A1 LOW-DOSE IL-1β-INDUCED PHOTORECEPTOR CELL RESCUE WITHOUT RETINAL DYSPLASIA
11/16/2000WO2000068265A1 Antimicrobial theta defensins and methods of using same
11/16/2000WO2000068264A2 A peptide inhibitor of fibrinogen blood clotting
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068262A1 Novel pollen antigen
11/16/2000WO2000068261A2 Attenuated microorganisms for the treatment of infection
1 ... 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 ... 2916